kainic acid has been researched along with Akinetic-Rigid Variant of Huntington Disease in 76 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 53 (69.74) | 18.7374 |
1990's | 15 (19.74) | 18.2507 |
2000's | 7 (9.21) | 29.6817 |
2010's | 1 (1.32) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mazurová, Y; Osterreicher, J; Valousková, V | 1 |
Barton, SJ; Bunner, KD; Dorner, JL; Gaither, TW; Klein, EL; Miller, BR; Rebec, GV | 1 |
Choi, DW; Lee, CS; Macdonald, ME; Moss, JL; Revilla, FJ; Snider, BJ; Wheeler, VC | 1 |
Guidetti, P; Pellicciari, R; Sapko, MT; Schwarcz, R; Tagle, DA; Yu, P | 1 |
McLin, JP; Steward, O; Thompson, LM | 1 |
Ciliax, BJ; Pan, HS; Penney, JB; Young, AB | 1 |
Arnason, BG; Beutler, BA; Noronha, AB; Poon, MM | 1 |
Johnston, GA; Sanberg, PR | 1 |
McGeer, EG; McGeer, PL; Wong, PT | 1 |
Carter, CJ | 2 |
Bird, ED; Hefti, F; Melamed, E | 1 |
Levin, SL; Sytinskiĭ, IA | 1 |
Köhler, C; Schwarcz, R | 1 |
Coyle, JT; Deckel, AW; Robinson, RG; Sanberg, PR | 1 |
Hunter, JF; Rieke, GK; Scarfe, AD | 1 |
Bioulac, B; Doudet, D; Gross, C | 1 |
Butterfield, DA; Markesbery, WR | 1 |
Brennan, MJ; Kramer, S; Metz, J; van der Westhuyzen, J | 1 |
McGeer, EG; McGeer, PL | 3 |
Deshmukh, P; Morelli, M; Schoemaker, H; Yamamura, HI | 1 |
Finch, CE | 1 |
Krammer, EB | 1 |
Kimura, H; McGeer, EG; McGeer, PL | 1 |
Bird, ED; Coyle, JT; London, ED; Yamamura, HI | 1 |
Bernheimer, H; Higatsberger, MR; Hornykiewicz, O; Shannak, KS; Sperk, G | 1 |
Choi, D; Gottron, F; Turetsky, D | 1 |
Folstein, SE; Hedreen, JC; Peyser, CE; Ross, CA; Wagster, MV | 1 |
Albin, RL; Kremer, B; Tallaksen-Greene, SJ | 1 |
Dodd, PR; Johnston, GA; Leong, DK | 1 |
Akiyama, A; Nakazato, T | 1 |
Bernardi, G; Calabresi, P; Centonze, D; Gubellini, P; Marfia, GA; Pisani, A; Sancesario, G | 1 |
Alberch, J; Arenas, E; Canals, JM; Checa, N; Marco, S; Michels, A; Pérez-Navarro, E | 1 |
Leavens, W; Morton, AJ | 1 |
Akerud, P; Alberch, J; Arenas, E; Canals, JM; Checa, N; Marco, S; Michels, A; Pérez-Navarro, E; Tolosa, E | 1 |
Giordano, M; Mejía-Viggiano, MC | 1 |
Fibiger, HC; Mason, ST; Sanberg, PR | 1 |
Fibiger, HC; Lehmann, J; Sanberg, PR | 2 |
Fibiger, HC; Mason, ST | 2 |
Coyle, JT | 1 |
Carolei, A; Del Castillo, G | 1 |
de Gubareff, T; Olney, JW | 1 |
McGeer, EG; McGeer, PL; Singh, K | 1 |
Friedle, NM; Kelly, PH; Moore, KE | 1 |
Bennett, JP; Coyle, JT; Schwarcz, R | 1 |
Coyle, JT; Harris, LW; Heyl, WC; London, ED | 1 |
Beaumont, K; Bird, ED; Fields, JZ; Maurin, Y; Reisine, TD; Spokes, E; Yamamura, HI | 1 |
Fibiger, HC; Sanberg, PR | 1 |
Henke, H | 1 |
Borison, RL; Diamond, BI | 1 |
McGeer, EG; Singh, EA | 1 |
Arregui, A; Emson, PC; Spokes, EG | 1 |
Bennett, JP; Campochiaro, P; Coyle, JT; Schwarcz, R | 1 |
Cotton, P | 1 |
Dure, LS; Penney, JB; Young, AB | 1 |
Dodd, PR; Johnston, GA; Morrison, MM; Ruwoldt, A; Smith, AI; Walls, RS; Watson, WE | 1 |
Beal, MF; Ferrante, RJ; Kowall, NW; Swartz, KJ | 1 |
Ford, LM; Giordano, M; Sanberg, PR; Shipley, MT | 1 |
Kanazawa, I | 1 |
Norman, AB; Pratt, RG; Samaratunga, RC; Sanberg, PR; Thomas, SR | 1 |
Jhamandas, K; Ruzicka, BB | 1 |
Giòrdano, M; Hagenmeyer-Houser, SH; Henault, MA; Nash, DR; Ragozzino, ME; Sanberg, PR | 1 |
Gray, PN; May, PC | 1 |
Beal, MF; Burd, GD; Landis, DM; Marshall, PE; Martin, JB | 1 |
Choi, DW; Koh, JY; Peters, S | 1 |
Bioulac, B; Doudet, D; Gross, C; Pouchot, C | 1 |
Matyja, E | 1 |
Allen, GS; Huang, S; Tulipan, N; Whetsell, WO | 1 |
Deckel, AW; Henault, MA; Sanberg, PR | 1 |
Marasigan, SM; Miyoshi, K; Sato, M | 1 |
Go, KG; Gramsbergen, JB; Korf, J; Prenen, GH | 1 |
Giordano, M; Hagenmeyer-Houser, SH; Sanberg, PR | 1 |
9 review(s) available for kainic acid and Akinetic-Rigid Variant of Huntington Disease
Article | Year |
---|---|
Glutamate and Huntington's disease.
Topics: Age Factors; Animals; Basal Ganglia; Glutamates; Humans; Huntington Disease; Kainic Acid; Models, Biological; Neurons; Neurotransmitter Agents; Psychotropic Drugs; Rats; Receptors, Dopamine; Synapses | 1981 |
[Toxic action of kainic acid as a model of Huntington chorea and epilepsy (review)].
Topics: Animals; Anticonvulsants; Behavior, Animal; Corpus Striatum; Disease Models, Animal; Drug Interactions; gamma-Aminobutyric Acid; Hippocampus; Humans; Huntington Disease; Kainic Acid; Pyrrolidines; Rats; Seizures; Substantia Nigra | 1983 |
Huntington's disease: a generalized membrane defect.
Topics: Animals; Blood Platelets; Cell Membrane; Electron Spin Resonance Spectroscopy; Erythrocyte Aging; Erythrocyte Membrane; Erythrocytes; gamma-Aminobutyric Acid; Humans; Huntington Disease; Kainic Acid; Lipid Bilayers; Lymphocytes; Membrane Lipids; Membrane Proteins; Neurons; Rats; Skin | 1981 |
Kainic acid: The neurotoxic breakthrough.
Topics: Animals; Epilepsy; Hippocampus; Huntington Disease; Kainic Acid; Neurotoxins; Pyrrolidines; Receptors, Cell Surface; Receptors, Glutamate; Retina | 1982 |
The relationships of aging changes in the basal ganglia to manifestations of Huntington's chorea.
Topics: Adenylyl Cyclases; Aging; Animals; Basal Ganglia; Cell Survival; Disease Models, Animal; Dopamine; Humans; Huntington Disease; Kainic Acid; Mice; Mice, Inbred CBA; Rats; Receptors, Dopamine; Species Specificity; Substantia Nigra | 1980 |
[Recent neurobiological and related pharmaco-therapeutic acquisitions in Huntington's chorea].
Topics: Amphetamine; Antipsychotic Agents; Brain; Butyrophenones; gamma-Aminobutyric Acid; Humans; Huntington Disease; Kainic Acid; Levodopa; Lithium; Neurotransmitter Agents; Phenothiazines; Sympatholytics; Tetrabenazine | 1979 |
Use of the neurotoxic agents kainic acid and tetanus toxin in the extrapyramidal system.
Topics: Animals; Brain; Cerebellum; Extrapyramidal Tracts; gamma-Aminobutyric Acid; Hippocampus; Huntington Disease; Hydroxydopamines; Hypothalamo-Hypophyseal System; Kainic Acid; Neurotoxins; Pyrrolidines; Rats; Retina; Tetanus Toxin | 1979 |
[Model of choreic movement in monkey--contribution for understanding the mechanism of chorea in Huntington's disease].
Topics: Animals; Disease Models, Animal; Dopamine; Haplorhini; Huntington Disease; Kainic Acid; Levodopa | 1990 |
Cation shifts and excitotoxins in Alzheimer and Huntington disease and experimental brain damage.
Topics: Aged; Alzheimer Disease; Amino Acids; Animals; Brain; Brain Diseases; Calcium; Cations; gamma-Aminobutyric Acid; Humans; Huntington Disease; Kainic Acid; Middle Aged; Neurotoxins; Tetrodotoxin | 1986 |
67 other study(ies) available for kainic acid and Akinetic-Rigid Variant of Huntington Disease
Article | Year |
---|---|
[An animal model of Huntington's disease: the development of histopathological changes within the neurotoxic lesions of the striatum in long-term surviving rats].
Topics: Animals; Corpus Striatum; Disease Models, Animal; Huntington Disease; Ibotenic Acid; Kainic Acid; Neurotoxins; Rats; Rats, Long-Evans | 2002 |
Up-regulation of GLT1 reverses the deficit in cortically evoked striatal ascorbate efflux in the R6/2 mouse model of Huntington's disease.
Topics: Animals; Ascorbic Acid; Ascorbic Acid Deficiency; Aspartic Acid; Ceftriaxone; Cerebral Cortex; Corpus Striatum; Electric Stimulation; Excitatory Amino Acid Transporter 2; Extracellular Fluid; Genotype; Huntington Disease; Kainic Acid; Male; Mice; Mice, Transgenic; Microinjections; Transcription, Genetic; Up-Regulation | 2012 |
Neocortical neurons cultured from mice with expanded CAG repeats in the huntingtin gene: unaltered vulnerability to excitotoxins and other insults.
Topics: Animals; Apoptosis; Cell Culture Techniques; Gene Expression; Genotype; Huntingtin Protein; Huntington Disease; Immunoblotting; Immunohistochemistry; Kainic Acid; Mice; Mice, Transgenic; N-Methylaspartate; Neocortex; Nerve Tissue Proteins; Neurons; Neurotoxins; Nuclear Proteins; Oxidative Stress; Peptides; Trinucleotide Repeat Expansion | 2003 |
Endogenous kynurenate controls the vulnerability of striatal neurons to quinolinate: Implications for Huntington's disease.
Topics: Animals; Brain Chemistry; Excitatory Amino Acid Agonists; Huntington Disease; Kainic Acid; Kynurenic Acid; Kynurenine; Kynurenine 3-Monooxygenase; Mice; Mice, Knockout; Microinjections; Neostriatum; Neurons; Quinolinic Acid; Transaminases | 2006 |
Differential susceptibility to striatal neurodegeneration induced by quinolinic acid and kainate in inbred, outbred and hybrid mouse strains.
Topics: Animals; Chimera; Corpus Striatum; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance; Genetic Predisposition to Disease; Huntington Disease; Kainic Acid; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Inbred DBA; Mice, Inbred ICR; Nerve Degeneration; Neurons; Neurotoxins; Phenotype; Quinolinic Acid; Species Specificity | 2006 |
GABA and benzodiazepine receptors in basal ganglia function.
Topics: Animals; Basal Ganglia; Caudate Nucleus; Corpus Striatum; Disease Models, Animal; gamma-Aminobutyric Acid; Glutamate Decarboxylase; Huntington Disease; Kainic Acid; Neural Inhibition; Neural Pathways; Putamen; Rats; Receptors, Cell Surface; Receptors, GABA-A; Receptors, Opioid; Substantia Nigra; Synaptic Transmission | 1984 |
The absence of unique kainic acid-like molecules in urine, serum, and CSF from Huntington's disease patients.
Topics: Animals; Binding, Competitive; Brain; Glutamates; Glutamic Acid; Huntington Disease; Kainic Acid; Ketoglutaric Acids; Male; Pyrrolidines; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Receptors, Kainic Acid | 1981 |
Effects of kainic acid injection and cortical lesion on ornithine and aspartate aminotransferases in rat striatum.
Topics: Animals; Aspartate Aminotransferases; Corpus Striatum; Frontal Lobe; Glutamates; Glutamic Acid; Humans; Huntington Disease; Kainic Acid; Muridae; Neural Pathways; Ornithine-Oxo-Acid Transaminase; Parietal Lobe; Pyrrolidines; Transaminases | 1982 |
Increased alanine aminotransferase activity in the Huntington's disease putamen.
Topics: Alanine Transaminase; Animals; Corpus Striatum; Cytosol; Glutamate-Ammonia Ligase; Humans; Huntington Disease; Kainic Acid; Male; Middle Aged; Mitochondria; Putamen; Pyruvate Dehydrogenase Complex; Rats; Rats, Inbred Strains | 1984 |
Huntington chorea is not associated with hyperactivity of nigrostriatal dopaminergic neurons: studies in postmortem tissues and in rats with kainic acid lesions.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Diseases; Corpus Striatum; Dopamine; Female; Homovanillic Acid; Humans; Huntington Disease; Kainic Acid; Male; Middle Aged; Neurons; Rats; Rats, Inbred Strains | 1982 |
Differential vulnerability of central neurons of the rat to quinolinic acid.
Topics: Animals; Brain; Corpus Striatum; Diencephalon; Epilepsy, Temporal Lobe; Hippocampus; Huntington Disease; Ibotenic Acid; Kainic Acid; Male; Pyridines; Quinolinic Acid; Quinolinic Acids; Rats; Telencephalon | 1983 |
Reversal of long-term locomotor abnormalities in the kainic acid model of Huntington's disease by day 18 fetal striatal implants.
Topics: Animals; Behavior, Animal; Corpus Striatum; Disease Models, Animal; Female; Fetus; Huntington Disease; Kainic Acid; Locomotion; Pregnancy; Rats; Rats, Inbred Strains | 1983 |
Reduced GABA transaminase activity in the Huntington's disease putamen.
Topics: 4-Aminobutyrate Transaminase; Animals; Choline O-Acetyltransferase; Glutamate Decarboxylase; Humans; Huntington Disease; Kainic Acid; Putamen; Rats; Reference Values | 1984 |
L-pyroglutamate: an alternate neurotoxin for a rodent model of Huntington's disease.
Topics: Animals; Basal Ganglia; Basal Ganglia Diseases; Corpus Striatum; Disease Models, Animal; Huntington Disease; Kainic Acid; Male; Mice; Microscopy, Electron; Pyrrolidinones; Pyrrolidonecarboxylic Acid | 1984 |
[Activity of dopaminergic neurons of the substantia nigra following lesions of the neostriatum by kainic acid].
Topics: Action Potentials; Animals; Caudate Nucleus; Disease Models, Animal; Dopamine; Electrophysiology; Huntington Disease; Kainic Acid; Male; Neurons; Putamen; Pyrrolidines; Rats; Rats, Inbred Strains; Substantia Nigra | 1984 |
Neurotoxicity of folates: implications for vitamin B12 deficiency and Huntington's chorea.
Topics: Animals; Brain; Chemical Phenomena; Chemistry; Chiroptera; Folic Acid; gamma-Aminobutyric Acid; Humans; Huntington Disease; Kainic Acid; Models, Biological; Rats; Receptors, Cell Surface; Receptors, Kainic Acid; Tetrahydrofolates; Vitamin B 12 Deficiency | 1981 |
[3H]Ro5-4864 benzodiazepine binding in the kainate lesioned striatum and Huntington's diseased basal ganglia.
Topics: Aged; Animals; Benzodiazepinones; Binding Sites; Corpus Striatum; Flunitrazepam; Humans; Huntington Disease; Kainic Acid; Male; Middle Aged; Neuroglia; Pyrrolidines; Rats; Rats, Inbred Strains; Receptors, Drug; Receptors, GABA-A | 1982 |
Anterograde and transsynaptic degeneration 'en cascade' in basal ganglia induced by intrastriatal injection of kainic acid: an animal analogue of Huntington's disease.
Topics: Acetylcholinesterase; Animals; Basal Ganglia; Corpus Striatum; Disease Models, Animal; Female; Globus Pallidus; Huntington Disease; Kainic Acid; Male; Nerve Degeneration; Neurons; Pyrrolidines; Rats; Substantia Nigra; Synapses | 1980 |
Metabolic alterations in an animal model of Huntington's disease using the 14C-deoxyglucose method.
Topics: Animals; Autoradiography; Deoxy Sugars; Deoxyglucose; Disease Models, Animal; Huntington Disease; Kainic Acid; Male; Rats | 1980 |
Decreased receptor-binding sites for kainic acid in brains of patients with Huntington's disease.
Topics: Adult; Animals; Binding Sites; Brain Chemistry; Caudate Nucleus; Female; Frontal Lobe; Humans; Huntington Disease; Kainic Acid; Male; Middle Aged; Postmortem Changes; Putamen; Pyrrolidines; Rats; Receptors, Drug | 1981 |
Striatal ganglioside levels in the rat following kainic acid lesions: comparison with Huntington's disease.
Topics: Animals; Brain Chemistry; Corpus Striatum; Disease Models, Animal; Gangliosides; Humans; Huntington Disease; Kainic Acid; Male; Pyrrolidines; Rats; Tissue Distribution | 1981 |
SMI-32 antibody against non-phosphorylated neurofilaments identifies a subpopulation of cultured cortical neurons hypersensitive to kainate toxicity.
Topics: Alzheimer Disease; Animals; Antibodies, Monoclonal; Cell Death; Cells, Cultured; Cerebral Cortex; Huntington Disease; Hypersensitivity; Immunohistochemistry; Kainic Acid; Mice; Mice, Inbred Strains; Neurofilament Proteins; Neurons | 1995 |
Selective loss of [3H]kainic acid and [3H]AMPA binding in layer VI of frontal cortex in Huntington's disease.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Autoradiography; Frontal Lobe; Humans; Huntington Disease; Kainic Acid; Middle Aged; Neurons; Receptors, AMPA; Receptors, Glutamate; Receptors, Kainic Acid; Receptors, N-Methyl-D-Aspartate; Reference Values; Tritium | 1994 |
AMPA and NMDA binding sites in the hypothalamic lateral tuberal nucleus: implications for Huntington's disease.
Topics: Aged; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Glutamates; Glutamic Acid; Humans; Huntington Disease; Hypothalamic Area, Lateral; Ibotenic Acid; Kainic Acid; Middle Aged; N-Methylaspartate; Receptors, N-Methyl-D-Aspartate | 1993 |
Brain extracts containing a Huntington disease antigen inhibit [3H]kainate binding and block synaptosomal amino acid transport.
Topics: Amino Acids; Animals; Antigens; Biological Transport; Brain; Excitatory Amino Acid Antagonists; GABA Antagonists; Glutamic Acid; Huntington Disease; Kainic Acid; Rats; Rats, Sprague-Dawley; Synaptosomes; Tissue Extracts; Tritium | 1993 |
In vivo electrochemical measurement of the long-lasting release of dopamine and serotonin induced by intrastriatal kainic acid.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Ascorbic Acid; Circadian Rhythm; Corpus Striatum; Dopamine; Electrochemistry; Huntington Disease; Kainic Acid; Kinetics; Male; Microinjections; Rats; Rats, Wistar; Serotonin; Time Factors | 1997 |
Striatal spiny neurons and cholinergic interneurons express differential ionotropic glutamatergic responses and vulnerability: implications for ischemia and Huntington's disease.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Brain Ischemia; Cells, Cultured; Cerebral Cortex; Cholinergic Fibers; Corpus Striatum; Electrophysiology; Excitatory Amino Acid Agonists; Excitatory Postsynaptic Potentials; Huntington Disease; Interneurons; Kainic Acid; Membrane Potentials; N-Methylaspartate; Neurotoxins; Rats; Rats, Wistar; Receptors, AMPA; Receptors, Glutamate; Receptors, Kainic Acid; Receptors, N-Methyl-D-Aspartate; Synaptic Transmission | 1998 |
Differential regulation of the expression of nerve growth factor, brain-derived neurotrophic factor, and neurotrophin-3 after excitotoxicity in a rat model of Huntington's disease.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Brain-Derived Neurotrophic Factor; Cycloleucine; Excitatory Amino Acid Agonists; Huntington Disease; Kainic Acid; Male; Neostriatum; Nerve Growth Factors; Neuroprotective Agents; Neurotrophin 3; Quinolinic Acid; Rats; Rats, Sprague-Dawley; RNA, Messenger | 1998 |
Mice transgenic for the human Huntington's disease mutation have reduced sensitivity to kainic acid toxicity.
Topics: Animals; Brain; Cell Nucleus; Drug Resistance; Hindlimb; Hippocampus; Humans; Huntington Disease; Inclusion Bodies; Kainic Acid; Mice; Mice, Transgenic; Mutation; Neurons; Pyramidal Cells; Seizures; Survival Analysis; Time Factors | 2000 |
Expression of brain-derived neurotrophic factor in cortical neurons is regulated by striatal target area.
Topics: 3T3 Cells; Animals; Axonal Transport; Brain-Derived Neurotrophic Factor; Cerebral Cortex; Colchicine; Corpus Striatum; Disease Models, Animal; Fibroblasts; Fluorescent Dyes; Hippocampus; Huntington Disease; In Situ Hybridization; Kainic Acid; Male; Mice; Microinjections; Neural Pathways; Neurons; Nitro Compounds; Propionates; Quinolinic Acid; Rats; Rats, Inbred F344; Rats, Sprague-Dawley; RNA, Messenger; Stilbamidines; Up-Regulation | 2001 |
Gender differences in spontaneous and MK-801-induced activity after striatal lesions.
Topics: Animals; Disease Models, Animal; Dizocilpine Maleate; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Female; Huntington Disease; Hyperkinesis; Kainic Acid; Male; Motor Activity; Neostriatum; Neurons; Neurotoxins; Rats; Rats, Wistar; Sex Characteristics | 2001 |
Kainic acid lesions of the striatum dissociate amphetamine and apomorphine stereotypy: similarities to Huntingdon's chorea.
Topics: Animals; Apomorphine; Behavior; Choline O-Acetyltransferase; Corpus Striatum; Dextroamphetamine; Disease Models, Animal; Glutamate Decarboxylase; Humans; Huntington Disease; Kainic Acid; Male; Nucleus Accumbens; Pyrrolidines; Rats; Stereotyped Behavior; Tyrosine 3-Monooxygenase | 1978 |
Impaired learning and memory after kainic acid lesions of the striatum: a behavioral model of Huntington's disease.
Topics: Animals; Avoidance Learning; Cerebral Cortex; Choline O-Acetyltransferase; Corpus Striatum; Disease Models, Animal; Glutamate Decarboxylase; Huntington Disease; Kainic Acid; Male; Memory; Mental Recall; Motor Activity; Pyrrolidines; Rats; Retention, Psychology; Tyrosine 3-Monooxygenase | 1978 |
Kainic acid lesions of the striatum: behavioural sequalae similar to Huntington's chorea.
Topics: Animals; Apomorphine; Cerebral Cortex; Choline O-Acetyltransferase; Corpus Striatum; Dextroamphetamine; Disease Models, Animal; Dose-Response Relationship, Drug; Glutamate Decarboxylase; Habituation, Psychophysiologic; Humans; Huntington Disease; Kainic Acid; Male; Motor Activity; Neurons; Nucleus Accumbens; Pyrrolidines; Rats; Stereotyped Behavior; Tyrosine 3-Monooxygenase | 1978 |
Intracerebral injections of kainic acid and tetanus toxin: possible models for the signs of chorea and dystonia.
Topics: Animals; Biogenic Amines; Brain Chemistry; Choline O-Acetyltransferase; Corpus Striatum; Disease Models, Animal; Dystonia Musculorum Deformans; Glutamate Decarboxylase; Humans; Huntington Disease; Kainic Acid; Pyrrolidines; Rats; Substantia Nigra; Tetanus Toxin; Thalamus; Tyrosine 3-Monooxygenase | 1978 |
Kainic acid lesions of the striatum in rats mimic the spontaneous motor abnormalities of Huntington's Disease.
Topics: Animals; Behavior, Animal; Choline O-Acetyltransferase; Corpus Striatum; Disease Models, Animal; Glutamate Decarboxylase; Huntington Disease; Kainic Acid; Male; Motor Activity; Pimozide; Pyrrolidines; Rats; Tyrosine 3-Monooxygenase | 1979 |
An animal model for Huntington's disease.
Topics: Animals; Choline O-Acetyltransferase; Corpus Striatum; Disease Models, Animal; gamma-Aminobutyric Acid; Glutamate Decarboxylase; Glutamates; Huntington Disease; Kainic Acid; Nerve Degeneration; Neural Pathways; Rats; Receptors, Neurotransmitter; Substantia Nigra; Tyrosine 3-Monooxygenase | 1979 |
Glutamate neurotoxicity and Huntington's chorea.
Topics: Animals; Corpus Striatum; gamma-Aminobutyric Acid; Glutamates; Huntington Disease; Injections; Kainic Acid; Male; Neurons; Rats | 1978 |
Kainate-induced degeneration of neostriatal neurons: dependency upon corticostriatal tract.
Topics: Animals; Cerebral Cortex; Corpus Striatum; Efferent Pathways; Glutamates; Huntington Disease; In Vitro Techniques; Kainic Acid; Male; Nerve Degeneration; Pyrrolidines; Rats | 1978 |
Regional brain atrophy and reductions in glutamate release and uptake after intrastriatal kainic acid.
Topics: Animals; Brain; Brain Chemistry; Cerebral Cortex; Corpus Striatum; Disease Models, Animal; Dopamine; Glutamate Decarboxylase; Glutamates; Huntington Disease; Kainic Acid; Male; Pyrrolidines; Rats | 1978 |
Inhibitors of GABA metabolism: implications for Huntington's disease.
Topics: 4-Aminobutyrate Transaminase; Alkynes; Aminocaproates; Aminocaproic Acid; Animals; Caudate Nucleus; gamma-Aminobutyric Acid; Glutamate Decarboxylase; Huntington Disease; Kainic Acid; Male; Nerve Degeneration; Rats; Substantia Nigra; Transaminases; Valproic Acid | 1977 |
Effect of 2-dimethylaminoethanol in kainate-lesioned rat striatum: anomaly in the radioenzymatic assay of acetylcholine.
Topics: Acetylcholine; Animals; Brain Chemistry; Choline; Chromatography, Gas; Corpus Striatum; Deanol; Disease Models, Animal; Ethanolamines; Huntington Disease; Kainic Acid; Male; Phosphorus Radioisotopes; Pyrrolidines; Rats | 1978 |
Huntington's disease and its animal model: alterations in kainic acid binding.
Topics: Animals; Binding Sites; Caudate Nucleus; Choline O-Acetyltransferase; Corpus Striatum; Disease Models, Animal; Huntington Disease; Kainic Acid; Kinetics; Male; Putamen; Pyrrolidines; Rats; Synaptic Membranes; Time Factors | 1979 |
Sedative effects of apomorphine in an animal model of Huntington's disease.
Topics: Animals; Apomorphine; Corpus Striatum; Dextroamphetamine; Disease Models, Animal; Humans; Huntington Disease; Kainic Acid; Male; Motor Activity; Rats; Receptors, Dopamine; Stereotyped Behavior | 1979 |
Body weight, feeding, and drinking behaviors in rats with kainic acid-induced lesions of striatal neurons--with a note on body weight symptomatology in Huntington's disease.
Topics: Animals; Body Weight; Brain Diseases; Corpus Striatum; Disease Models, Animal; Drinking Behavior; Feeding Behavior; Huntington Disease; Kainic Acid; Male; Pyrrolidines; Rats | 1979 |
Kainic acid binding in human caudate nucleus: effect of Huntington's disease.
Topics: Binding, Competitive; Caudate Nucleus; Glutamates; Humans; Huntington Disease; Kainic Acid; Molecular Conformation; Pyrrolidines; Stereoisomerism | 1979 |
Kainic acid animal model predicts therapeutic agents in Huntington's chorea.
Topics: Animals; Disease Models, Animal; Drug Evaluation, Preclinical; Humans; Huntington Disease; Kainic Acid; Male; Pyrrolidines; Rats | 1979 |
Angiotensin converting enzyme in kainic acid--injected striata.
Topics: Animals; Choline O-Acetyltransferase; Corpus Striatum; Glutamate Decarboxylase; Huntington Disease; Injections; Kainic Acid; Male; Peptidyl-Dipeptidase A; Pyrrolidines; Rats | 1978 |
Angiotensin-converting enzyme in substantia nigra: reduction of activity in Huntington's disease and after intrastriatal kainic acid in rats.
Topics: Animals; Caudate Nucleus; Corpus Striatum; Humans; Huntington Disease; Kainic Acid; Male; Nucleus Accumbens; Peptidyl-Dipeptidase A; Putamen; Pyrrolidines; Rats; Substantia Nigra | 1978 |
Clinical, neuropathologic and pharmacologic aspects of Huntington's disease: correlates with a new animal model.
Topics: Animals; Brain; Corpus Striatum; Disease Models, Animal; gamma-Aminobutyric Acid; Humans; Huntington Disease; Kainic Acid; Pyrrolidines; Rats; Receptors, Cholinergic; Substantia Nigra; Synaptic Transmission | 1977 |
Neuroscientists begin to piece together more parts of Huntington's disease puzzle.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Biomarkers; Brain Chemistry; Disease Models, Animal; Fibroblast Growth Factors; Humans; Huntington Disease; Ibotenic Acid; Kainic Acid; Lactates; Lactic Acid; Rats | 1992 |
Excitatory amino acid binding sites in the caudate nucleus and frontal cortex of Huntington's disease.
Topics: Adolescent; Adult; Age Factors; Aged; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Binding, Competitive; Caudate Nucleus; Cell Death; Child; Dizocilpine Maleate; Frontal Lobe; Glycine; Humans; Huntington Disease; Ibotenic Acid; Kainic Acid; Middle Aged; N-Methylaspartate; Phencyclidine; Receptors, AMPA; Receptors, Glutamate; Receptors, Glycine; Receptors, Kainic Acid; Receptors, Metabotropic Glutamate; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotransmitter; Receptors, Phencyclidine | 1991 |
The interaction of a Huntington disease factor with receptors for the neurotoxin kainic acid.
Topics: Animals; Brain; Cerebral Cortex; Chromatography, High Pressure Liquid; Corpus Striatum; Humans; Huntington Disease; In Vitro Techniques; Kainic Acid; Leukocytes; Rats; Receptors, Kainic Acid; Receptors, Neurotransmitter; Spectrophotometry, Ultraviolet; Subcellular Fractions; Synaptic Membranes | 1991 |
Chronic quinolinic acid lesions in rats closely resemble Huntington's disease.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Atrophy; Biogenic Amines; Cerebral Cortex; Choline O-Acetyltransferase; Corpus Striatum; Disease Models, Animal; gamma-Aminobutyric Acid; Glutamates; Huntington Disease; Ibotenic Acid; Kainic Acid; Male; Mesencephalon; NADPH Dehydrogenase; Neurons; Neuropeptide Y; Quinolinic Acid; Quinolinic Acids; Rats; Rats, Inbred Strains; Reference Values; Somatostatin; Substance P | 1991 |
Neural grafts and pharmacological intervention in a model of Huntington's disease.
Topics: Acetylcholinesterase; Amphetamine; Animals; Brain Tissue Transplantation; Catalepsy; Cerebral Cortex; Corpus Striatum; Dizocilpine Maleate; Electron Transport Complex IV; Female; Fetal Tissue Transplantation; Huntington Disease; Immunohistochemistry; Kainic Acid; Motor Activity; Nerve Degeneration; Pregnancy; Quinolinic Acid; Quinolinic Acids; Rats; Rats, Inbred Strains | 1990 |
T1 and T2 weighted magnetic resonance imaging of excitotoxin lesions and neural transplants in rat brain in vivo.
Topics: Animals; Corpus Striatum; Disease Models, Animal; Huntington Disease; Kainic Acid; Magnetic Resonance Imaging; Male; Rats; Rats, Inbred Strains | 1990 |
Elevation of Met-enkephalin-like immunoreactivity in the rat striatum and globus pallidus following the focal injection of excitotoxins.
Topics: Animals; Corpus Striatum; Enkephalin, Methionine; Globus Pallidus; Huntington Disease; Injections; Kainic Acid; Male; N-Methylaspartate; Neurotoxins; Quinolinic Acid; Quinolinic Acids; Quisqualic Acid; Radioimmunoassay; Rats; Rats, Inbred Strains | 1990 |
Intraparenchymal striatal transplants required for maintenance of behavioral recovery in an animal model of Huntington's disease.
Topics: Analysis of Variance; Animals; Brain Tissue Transplantation; Corpus Striatum; Disease Models, Animal; Electroshock; Huntington Disease; Kainic Acid; Male; Motor Activity; Rats; Rats, Inbred Strains | 1989 |
L-Homocysteic acid as an alternative cytotoxin for studying glutamate-induced cellular degeneration of Huntington's disease and normal skin fibroblasts.
Topics: Aspartic Acid; Cell Survival; Cells, Cultured; Cysteic Acid; Cysteine; Fibroblasts; Glutamates; Glutamic Acid; Homocysteine; Humans; Huntington Disease; In Vitro Techniques; Isomerism; Kainic Acid; Kinetics; N-Methylaspartate; Neurotransmitter Agents; Skin; Time Factors | 1985 |
Excitotoxin lesions do not mimic the alteration of somatostatin in Huntington's disease.
Topics: Animals; Brain; Corpus Striatum; Disease Models, Animal; Enkephalin, Leucine; Humans; Huntington Disease; Ibotenic Acid; Immune Sera; Immunoassay; Kainic Acid; Male; Neurons; Radioimmunoassay; Rats; Rats, Inbred Strains; Somatostatin; Tissue Distribution | 1985 |
Neurons containing NADPH-diaphorase are selectively resistant to quinolinate toxicity.
Topics: Animals; Aspartic Acid; Glutamates; Glutamic Acid; Humans; Huntington Disease; Kainic Acid; Mice; N-Methylaspartate; NADH, NADPH Oxidoreductases; NADPH Dehydrogenase; Neurons; Oxadiazoles; Pyridines; Quinolinic Acid; Quinolinic Acids; Quisqualic Acid | 1986 |
[Activity of substantia nigra pars reticulata neurons after lesion of the ipsilateral neostriatum by kainic acid in rats].
Topics: Animals; Caudate Nucleus; Disease Models, Animal; Electrophysiology; Huntington Disease; Kainic Acid; Male; Neurons; Putamen; Rats; Rats, Inbred Strains; Substantia Nigra | 1985 |
Morphologic evidence of a primary response of gila to kainic acid administration into the rat neostriatum; studied in vivo and in vitro.
Topics: Animals; Astrocytes; Corpus Striatum; Culture Media; Huntington Disease; Injections; Kainic Acid; Microscopy, Electron; Neuroglia; Organ Culture Techniques; Rats; Rats, Inbred Strains; Time Factors | 1986 |
Neonatal striatal grafts prevent lethal syndrome produced by bilateral intrastriatal injection of kainic acid.
Topics: Animals; Animals, Newborn; Basal Ganglia Diseases; Corpus Striatum; Disease Models, Animal; Female; Huntington Disease; Kainic Acid; Rats; Rats, Inbred Lew | 1986 |
Locomotor hyperactivity: effects of multiple striatal transplants in an animal model of Huntington's disease.
Topics: Animals; Corpus Striatum; Disease Models, Animal; Fetus; Huntington Disease; Kainic Acid; Male; Rats | 1986 |
Experimental striatal degeneration induced by kainic acid administration: relevance to morphological changes in Huntington's disease.
Topics: Animals; Corpus Striatum; Disease Models, Animal; Huntington Disease; Kainic Acid; Male; Microinjections; Microscopy, Electron; Nerve Degeneration; Rats; Rats, Inbred Strains; Stereotaxic Techniques | 1986 |
Intraparenchymal fetal striatal transplants and recovery in kainic acid lesioned rats.
Topics: Animals; Corpus Striatum; Disease Models, Animal; Fetus; Huntington Disease; Kainic Acid; Motor Activity; Rats | 1988 |